Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Efthymios Manolis

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|October 22, 2009
Proposals for model-based paediatric medicinal development within the current European Union regulatory frameworkEfthymios Manolis, Gérard Pons
Clinical Pharmacokinetics|September 8, 2011
Pharmacometrics for regulatory decision making: status and perspectiveEfthymios Manolis, Ralf Herold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Hollow Fiber System Model for Tuberculosis: The European Medicines Agency ExperienceMarco Cavaleri, Efthymios Manolis
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 15, 2017
Chest imaging in CF studies - CommentaryIrmgard Eichler, Efthymios Manolis
Proteomics. Clinical Applications|May 4, 2011
New pathway for qualification of novel methodologies in the European Medicines AgencyEfthymios Manolis, Spiros Vamvakas, Maria Isaac
Journal of Clinical Pharmacology|June 29, 2021
The European Medicines Agency Experience With Pediatric Dose SelectionEfthymios Manolis, Flora T Musuamba, Kristin E Karlsson
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2014
The European Medicines Agency experience with biomarker qualificationEfthymios Manolis, Armin Koch, Dieter Deforce, et al.
Clinical Pharmacology and Therapeutics|February 4, 2020
Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030Efthymios Manolis, Flora T Musuamba, Kristin E Karlsson
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal functionNassim Kamar, Etienne Chatelut, Efthymios Manolis, et al.
Clinical Pharmacology and Therapeutics|January 3, 2025
Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMAPolly Paul, Pieter J Colin, Flora Musuamba Tshinanu, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|October 22, 2009
Proposals for model-based paediatric medicinal development within the current European Union regulatory frameworkEfthymios Manolis, Gérard Pons
Clinical Pharmacokinetics|September 8, 2011
Pharmacometrics for regulatory decision making: status and perspectiveEfthymios Manolis, Ralf Herold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2015
Hollow Fiber System Model for Tuberculosis: The European Medicines Agency ExperienceMarco Cavaleri, Efthymios Manolis
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 15, 2017
Chest imaging in CF studies - CommentaryIrmgard Eichler, Efthymios Manolis
Proteomics. Clinical Applications|May 4, 2011
New pathway for qualification of novel methodologies in the European Medicines AgencyEfthymios Manolis, Spiros Vamvakas, Maria Isaac
Journal of Clinical Pharmacology|June 29, 2021
The European Medicines Agency Experience With Pediatric Dose SelectionEfthymios Manolis, Flora T Musuamba, Kristin E Karlsson
Methods in Molecular Biology (Clifton, N.J.)|November 12, 2014
The European Medicines Agency experience with biomarker qualificationEfthymios Manolis, Armin Koch, Dieter Deforce, et al.
Clinical Pharmacology and Therapeutics|February 4, 2020
Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030Efthymios Manolis, Flora T Musuamba, Kristin E Karlsson
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal functionNassim Kamar, Etienne Chatelut, Efthymios Manolis, et al.
Clinical Pharmacology and Therapeutics|January 3, 2025
Current Use of Physiologically Based Pharmacokinetic modeling in New Medicinal Product Approvals at EMAPolly Paul, Pieter J Colin, Flora Musuamba Tshinanu, et al.
Pageof 3